Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

China flag China · Delayed Price · Currency is CNY
102.59
+1.84 (1.83%)
At close: Mar 6, 2026
-13.32%
Market Cap 14.39B
Revenue (ttm) 630.37M
Net Income (ttm) 200.19M
Shares Out 137.75M
EPS (ttm) 1.46
PE Ratio 71.58
Forward PE 52.78
Dividend 0.80 (0.77%)
Ex-Dividend Date May 29, 2025
Volume 216,748
Average Volume 364,625
Open 100.49
Previous Close 100.75
Day's Range 100.25 - 104.00
52-Week Range 95.28 - 132.94
Beta 0.25
RSI 48.99
Earnings Date Apr 22, 2026

About SHA:688198

Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valv... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2005
Employees 670
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688198
Full Company Profile

Financial Performance

In 2025, SHA:688198's revenue was 630.37 million, an increase of 25.60% compared to the previous year's 501.88 million. Earnings were 200.19 million, an increase of 36.81%.

Financial Statements

News

There is no news available yet.